TC
DBD

Truvestments Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Truvestments Capital’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-42
Closed – – 973
2022
Q3 		$0 Hold
42
– – ﹤0.01% 667
2022
Q2 		$0 Buy
+42
New +$156 ﹤0.01% 657
2022
Q1 		– Sell
-42
Closed – – 598
2021
Q4 		$0 Sell
42
-200
-83% -$1.86K ﹤0.01% 667
2021
Q3 		$2K Hold
242
– – ﹤0.01% 560
2021
Q2 		$3K Hold
242
– – ﹤0.01% 532
2021
Q1 		$3K Buy
242
+200
+476% +$2.75K ﹤0.01% 598
2020
Q4 		$0 Buy
+42
New +$382 ﹤0.01% 620
2020
Q3 		– Sell
-195
Closed -$1K – 589
2020
Q2 		$1K Buy
195
+1
+0.5% +$5 ﹤0.01% 562
2020
Q1 		$0 Buy
+194
New +$1.64K ﹤0.01% 560
2019
Q4 		– Sell
-195
Closed -$2K – 647
2019
Q3 		$2K Hold
195
– – ﹤0.01% 672
2019
Q2 		$2K Sell
195
-1,679
-90% -$17.5K ﹤0.01% 693
2019
Q1 		$21K Buy
+1,874
New +$13.1K 0.02% 393
2018
Q3 		$9K Buy
+2,108
New +$15.4K ﹤0.01% 666

Other funds holding DBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Truvestments Capital's DBD Position: Q4 2022 in Review

Truvestments Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 42 shares.

Truvestments Capital first reported a position in DBD in Q3 2018 and held it in 13 quarters. The position peaked at $21K in Q1 2019. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Truvestments Capital reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Truvestments Capital sold 42 Diebold Nixdorf Incorporated shares in Q4 2022.
  • Truvestments Capital first reported a position in Diebold Nixdorf Incorporated in Q3 2018 and held it in 13 quarters.
  • Truvestments Capital's Diebold Nixdorf Incorporated position peaked at $21K in Q1 2019.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Truvestments Capital's 13F filing for Q4 2022, filed 14 Feb 2023.